The endocannabinoid anandamide inhibits the function of α4β2 nicotinic acetylcholine receptors

Molecular Pharmacology

Volumn 72, Issue 4, 2007, Pages 1024-1032

  Spivak, Charles E ^a   Lupica, Carl R ^a   Oz, Murat ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA4BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR; ANANDAMIDE; BOVINE SERUM ALBUMIN; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; ENDOCANNABINOID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; NICOTINIC RECEPTOR; RIMONABANT; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACETYLCHOLINE; ARACHIDONIC ACIDS; CELL LINE; HUMANS; KINETICS; PATCH-CLAMP TECHNIQUES; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTORS, NICOTINIC; SERUM ALBUMIN, BOVINE;

EID: 34748905313     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.036939     Document Type: Article

References (45)

1. Akk G, Shu HJ, Wang C, Steinbach JH, Zorumski CF, Covey DF, and Mennerick S (2005) Neurosteroid access to the GABAA receptor. J Neurosci 25:11605-11613.
2. Baenziger JE, Morris ML, Darsaut TE, and Ryan SE (2000) Effect of membrane lipid composition on the conformational equilibria of the nicotinic acetylcholine receptor. J Biol Chem 275:777-784.
3. Barann M, Molderings G, Bruss M, Bonisch H, Urban BW, and Gothert M (2002) Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br J Pharmacol 137:589-596.
4. Barrantes FJ (2004) Structural basis for lipid modulation of nicotinic acetylcholine receptor function. Brain Res Brain Res Rev 47:71-95.
5. Basavarajappa BS and Hungund BL (2002) Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview. Prostaglandins Leukot Essent Fatty Acids 66:287-299.
6. Bojesen IN and Hansen HS (2003) Binding of anandamide to bovine serum albumin. J Lipid Res 44:1790-1794.
7. Bojesen IN and Hansen HS (2006) Effect of an unstirred layer on the membrane permeability of anandamide. J Lipid Res 47:561-570.
8. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D, Jou J, Allen V, Tiongson E, Chefer SI, et al. (2006) Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 63:907-915.
9. Castañé A, Berrendero F, and Maldonado R (2005) The role of the cannabinoid system in nicotine addiction. Pharmacol Biochem Behav 81:381-386.
10. Chemin J, Monteil A, Perez-Reyes E, Nargeot J, and Lory P (2001) Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J 20:7033-7040.
11. Dani JA and Bertrand D (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47:699-6729.
12. Ellena JF, Blazing MA, and McNamee MG (1983) Lipid-protein interactions in reconstituted membranes containing acetylcholine receptor. Biochemistry 22: 5523-5535.
13. Fenster CP, Beckman ML, Parker JC, Sheffield EB, Whitworth TL, Quick MW, and Lester RA (1999) Regulation of α4β2 nicotinic receptor desensitization by calcium and protein kinase C. Mol Pharmacol 55:432-443.
14. Fisyunov A, Tsintsadze V, Min R, Burnashev N, and Lozovaya NA (2006) Cannabinoids modulate the P-type high voltage-activated calcium currents in Purkinje neurons. J Neurophysiol 96:1267-1277.
15. Freund TF, Katona I, and Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017-1066.
16. 2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 35:1-8.
17. Gonzalez S, Valenti M, de Miguel R, Fezza F, Fernandez-Ruiz J, Di Marzo V, and Ramos JA (2004) Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. Br J Pharmacol 143:455-464.
18. Hampson AJ, Bornheim LM, Scanziani M, Yost CS, Gray AT, Hansen BM, Leonoudakis DJ, and Bickler PE (1998) Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem 70:671-676.
19. Hejazi N, Zhou C, Oz M, Sun H, Ye JH, and Zhang L (2006) Δ9-Tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Mol Pharmacol 69:991-997.
20. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202.
21. Kamp F and Hamilton JA (1993) Movement of fatty acids, fatty acid analogues, and bile acids across phospholipid bilayers. Biochemistry 32:11074-11086.
22. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81.
23. Lambert DG, Ghataorre AS, and Nahorski SR (1989) Muscarinic receptor binding characteristics of a human neuroblastoma SK-N-SH and its clones SH-SY5Y and SH-EP1. Eur J Pharmacol 165:71-77.
24. Laviolette SR and van der Kooy D (2004) The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci 5:55-65.
25. Lundbaek JA (2006) Regulation of membrane protein function by lipid bilayer elasticity - a single molecule technology to measure the bilayer properties experienced by an embedded protein. J Phys Condens Matter 18:S1305-S1344.
26. Murase K, Ryu PD, and Randic M (1989) Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons. Neurosci Lett 103:56-63.
27. Nicholson RA, Liao C, Zheng J, David LS, Coyne L, Errington AC, Singh G, and Lees G (2003) Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res 978:194-204.
28. + channels by membrane lipids. Science 304:265-270.
29. Oz M (2006) Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids. Pharmacol Ther 111:114-144.
30. Oz M, Jackson S, Woods A, Morales M, and Zhang L (2005) Additive effects of endogenous cannabinoid anandamide and ethanol on α7-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J Pharmacol Exp Ther 313:1272-1280.
31. Oz M, Ravindran R, Zhang L, and Morales M (2003) Endogenous cannabinoid, anandamide inhibits neuronal nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J Pharmacol Exp Ther 306:1003-1010.
32. 7- nicotinic receptor-mediated currents in Xenopus oocytes. J Pharmacol Exp Ther 310:1152-1160.
33. Oz M, Tchugunova Y, and Dinc M (2004b) Differential effects of endocannabinoids and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids. Eur J Pharmacol 502:47-58.
34. 2+ fluxes in rabbit T-tubule membranes. Eur J Pharmacol 404:13-20.
35. 3 receptor-mediated responses in Xenopus oocytes. Synapse 46:150-156.
36. Pacheco MA, Pastoor TE, Lukas RJ, and Wecker L (2001) Characterization of human alpha4beta2 neuronal nicotinic receptors stably expressed in SH-EP1 cells. Neurochem Res 26:683-693.
37. Pacher P, Batkai S, and Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389-462.
38. Paradiso KG and Steinbach JH (2003) Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors. J Physiol 553:857-871.
39. + channels. Neuropharmacology 35:983-991.
40. Quick MW and Lester RA (2002) Desensitization of neuronal nicotinic receptors. J Neurobiol 53:457-478.
41. Sher E, Chen Y, Sharples TJ, Broad LM, Benedetti G, Zwart R, McPhie GI, Pearson KH, Baldwinson T, and De Filippi G (2004) Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity. Curr Top Med Chem 4:283-297.
42. Spivak CE, Oz M, Beglan CL, and Shrager RI (2006) Diffusion delays and unstirred layer effects at monolayer cultures of Chinese hamster ovary cells: radioligand binding, confocal microscopy, and mathematical simulations. Cell Biochem Biophys 45:43-58.
43. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC, and Lester HA (2004) Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306:1029-1032.
44. Viveros MP, Marco EM, and File SE (2006) Nicotine and cannabinoids: parallels, contrasts and interactions. Neurosci Biobehav Rev 30:1161-1181.
45. Wu J, Kuo YP, George AA, Xu L, Hu J, and Lukas RJ (2004) beta-Amyloid directly inhibits human α4β2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells. J Biol Chem 279:37842-37851.